Trump proposes U.S. auto tariffs could be 'in the neighbourhood' of 25% | CBC NewsTrump's trade measures could impose 25% tariffs on auto, semiconductor, and pharmaceutical imports, threatening to disrupt international trade.
Trump floats 25% auto, drug, chip tariffs, upping trade threatsTrump plans to impose 25% tariffs on imports like automobiles, semiconductors, and pharmaceuticals, expanding his trade war by targeting multiple sectors.
US begins inquiry into pharmaceutical and chip imports in bid to impose tariffsThe Trump administration is investigating tariffs on pharmaceuticals and semiconductors to boost national security and domestic manufacturing.
Trump's Tariff Threat for Drug imports Poses Big Political RisksTrump's tariff move on imported medicines could lead to higher drug prices and shortages.
Trump's Next Tariffs Target Could be Foreign-Made PharmaceuticalsTrump's proposed tariffs on pharmaceuticals aim to bring drug production back to the U.S. despite potential challenges faced by companies.
US remains by far the top market for German exports DW 04/14/2025The US is Germany's largest export market, accounting for about 10.4% of its total exports in 2024.
Trump proposes U.S. auto tariffs could be 'in the neighbourhood' of 25% | CBC NewsTrump's trade measures could impose 25% tariffs on auto, semiconductor, and pharmaceutical imports, threatening to disrupt international trade.
Trump floats 25% auto, drug, chip tariffs, upping trade threatsTrump plans to impose 25% tariffs on imports like automobiles, semiconductors, and pharmaceuticals, expanding his trade war by targeting multiple sectors.
US begins inquiry into pharmaceutical and chip imports in bid to impose tariffsThe Trump administration is investigating tariffs on pharmaceuticals and semiconductors to boost national security and domestic manufacturing.
Trump's Tariff Threat for Drug imports Poses Big Political RisksTrump's tariff move on imported medicines could lead to higher drug prices and shortages.
Trump's Next Tariffs Target Could be Foreign-Made PharmaceuticalsTrump's proposed tariffs on pharmaceuticals aim to bring drug production back to the U.S. despite potential challenges faced by companies.
US remains by far the top market for German exports DW 04/14/2025The US is Germany's largest export market, accounting for about 10.4% of its total exports in 2024.
Ancient kitchen secrets REVEALED: How garlic, ginger and green onions fight cancer and heart diseaseGarlic, ginger, and green onions are potent natural ingredients with significant health benefits, validated by modern science.
Combination of two cheap drugs could save lives after heart attack, study findsCombining statins and ezetimibe could significantly reduce heart attack and stroke risks in patients.
New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
New anti-obesity drugs already outperform OzempicSimplistic approaches to obesity are largely ineffective long-term; modern treatments show promise in addressing the condition more effectively.
Design-Around Victory: Amgen's Self-Buffering Innovation Regeneron's ClaimsThe Federal Circuit affirmed Amgen's biosimilar, emphasizing its unique formulation and contrasting it with prior rulings against other manufacturers.
'Food is Medicine': The (Intentionally) Missing Prescription in HealthcareHealthcare providers should embrace the 'Food is Medicine' movement as Americans demand nutrition guidance over pharmaceuticals.
Brexit a key factor in worst UK medicine shortages in four years, report saysDrug shortages in the UK are at a four-year high, largely attributed to Brexit-related supply chain issues.
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia | TechCrunchAI is increasingly shaping the healthcare sector with partnerships among tech giants and startups to enhance access and affordability.
New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
New anti-obesity drugs already outperform OzempicSimplistic approaches to obesity are largely ineffective long-term; modern treatments show promise in addressing the condition more effectively.
Design-Around Victory: Amgen's Self-Buffering Innovation Regeneron's ClaimsThe Federal Circuit affirmed Amgen's biosimilar, emphasizing its unique formulation and contrasting it with prior rulings against other manufacturers.
'Food is Medicine': The (Intentionally) Missing Prescription in HealthcareHealthcare providers should embrace the 'Food is Medicine' movement as Americans demand nutrition guidance over pharmaceuticals.
Brexit a key factor in worst UK medicine shortages in four years, report saysDrug shortages in the UK are at a four-year high, largely attributed to Brexit-related supply chain issues.
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia | TechCrunchAI is increasingly shaping the healthcare sector with partnerships among tech giants and startups to enhance access and affordability.
Lazarus' Is a Dark and Kinetic AdventureLazarus explores a dystopian future where a miracle drug turns deadly, prompting a desperate search for the antidote.
Shinichiro Watanabe's New Anime Isn't Groundbreaking, But It's Still Cool As HellLazarus is a new anime by Shinichirō Watanabe that aims to combine excitement with a complex narrative.The show features a revolutionary painkiller that hides a deadly secret, creating a race against time.
Lazarus' Is a Dark and Kinetic AdventureLazarus explores a dystopian future where a miracle drug turns deadly, prompting a desperate search for the antidote.
Shinichiro Watanabe's New Anime Isn't Groundbreaking, But It's Still Cool As HellLazarus is a new anime by Shinichirō Watanabe that aims to combine excitement with a complex narrative.The show features a revolutionary painkiller that hides a deadly secret, creating a race against time.
China, America and pay inject drama into AstraZeneca's AGMAstraZeneca's annual meeting is overshadowed by investigations and pay protests despite strong financial performance.
AstraZeneca investment deal didn't add up for UK taxpayer', says ministerAstraZeneca cancelled a £450 million investment in the UK due to financial disagreements with the government.
AstraZeneca to invest $2.5bn in drugs research and manfacturing in BeijingAstraZeneca invests $2.5 billion in Beijing to bolster research, moving past recent controversies while collaborating with local biotech firms.
AstraZeneca reports 38% jump in pre-tax profits to $8.7bnAstraZeneca's profits surged despite pulling back on investments due to unmet government support.
AstraZeneca: A strong pipeline is a big tailwind - London Business News | Londonlovesbusiness.comAstraZeneca aims for $80 billion in revenue by 2030, potentially exceeding $100 billion if growth continues.
China, America and pay inject drama into AstraZeneca's AGMAstraZeneca's annual meeting is overshadowed by investigations and pay protests despite strong financial performance.
AstraZeneca investment deal didn't add up for UK taxpayer', says ministerAstraZeneca cancelled a £450 million investment in the UK due to financial disagreements with the government.
AstraZeneca to invest $2.5bn in drugs research and manfacturing in BeijingAstraZeneca invests $2.5 billion in Beijing to bolster research, moving past recent controversies while collaborating with local biotech firms.
AstraZeneca reports 38% jump in pre-tax profits to $8.7bnAstraZeneca's profits surged despite pulling back on investments due to unmet government support.
AstraZeneca: A strong pipeline is a big tailwind - London Business News | Londonlovesbusiness.comAstraZeneca aims for $80 billion in revenue by 2030, potentially exceeding $100 billion if growth continues.
Senate Judiciary Committee to Consider Bills Targeting Pharma Patents and PricingCongress is reviewing drug patent regulation legislation based on refuted data.The Center for American Principles warns against bills influenced by misleading drug market data.
Trump Rescinds Biden's Order Aimed At Lowering Costs of Prescription DrugsTrump's rollback of drug pricing initiatives halts programs aimed at lowering costs for Medicare recipients.
Senate Judiciary Committee to Consider Bills Targeting Pharma Patents and PricingCongress is reviewing drug patent regulation legislation based on refuted data.The Center for American Principles warns against bills influenced by misleading drug market data.
Trump Rescinds Biden's Order Aimed At Lowering Costs of Prescription DrugsTrump's rollback of drug pricing initiatives halts programs aimed at lowering costs for Medicare recipients.
Drug giants in Ireland remain silent on future despite Donald Trump's aim to bring manufacturing back to the USIreland is a key player in global pharmaceutical production, employing 50,000 people and exporting €50bn annually.
'Days of America being ripped off are over' - White House confirms Trump will go ahead with tariffsIrish pharma exports to the US may face a significant decline due to impending tariffs.
Countdown to Trump's tariffs: Tanaiste holding talks with European counterparts todayIreland's food, drink, and pharma industries face potential threats from US tariffs, prompting urgent discussions with EU leadership.
Irish exports to the US increase by more than a third to record 72bn amid Trump tariff threatIreland's booming medical and pharmaceutical exports face risks from potential US tariffs despite significant growth.
Drug giants in Ireland remain silent on future despite Donald Trump's aim to bring manufacturing back to the USIreland is a key player in global pharmaceutical production, employing 50,000 people and exporting €50bn annually.
'Days of America being ripped off are over' - White House confirms Trump will go ahead with tariffsIrish pharma exports to the US may face a significant decline due to impending tariffs.
Countdown to Trump's tariffs: Tanaiste holding talks with European counterparts todayIreland's food, drink, and pharma industries face potential threats from US tariffs, prompting urgent discussions with EU leadership.
Irish exports to the US increase by more than a third to record 72bn amid Trump tariff threatIreland's booming medical and pharmaceutical exports face risks from potential US tariffs despite significant growth.
Tax Victory for Generic Drug Companies: Federal Circuit Affirms ANDA Litigation Expenses are DeductibleGeneric pharmaceutical companies can now deduct legal expenses from patent litigation as ordinary business expenses.
Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting InvalidationThe Federal Circuit reversed previous invalidity rulings on key pharmaceutical patents, emphasizing the significance of prosecution delays and patent term extensions.
Federal Circuit Highlights the Importance of Separating Claim Construction and Infringement Analysis When Dealing with After-Arising TechnologyThe Federal Circuit reversed the invalidation of Novartis' patent for lack of written description, affirming other findings of non-obviousness and enablement.
Other Barks & Bites for Friday, March 28: House Passes Interagency R&D Bills; CAFC Affirms Induced Infringement Finding Against Mylan; and Several Drug Patent Bills Introduced into CongressMylan's proposed ANDA label is found to likely induce infringement of Janssen's patent on antipsychotic treatments, according to the Federal Circuit.
Tax Victory for Generic Drug Companies: Federal Circuit Affirms ANDA Litigation Expenses are DeductibleGeneric pharmaceutical companies can now deduct legal expenses from patent litigation as ordinary business expenses.
Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting InvalidationThe Federal Circuit reversed previous invalidity rulings on key pharmaceutical patents, emphasizing the significance of prosecution delays and patent term extensions.
Federal Circuit Highlights the Importance of Separating Claim Construction and Infringement Analysis When Dealing with After-Arising TechnologyThe Federal Circuit reversed the invalidation of Novartis' patent for lack of written description, affirming other findings of non-obviousness and enablement.
Other Barks & Bites for Friday, March 28: House Passes Interagency R&D Bills; CAFC Affirms Induced Infringement Finding Against Mylan; and Several Drug Patent Bills Introduced into CongressMylan's proposed ANDA label is found to likely induce infringement of Janssen's patent on antipsychotic treatments, according to the Federal Circuit.
This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used to attract investors.Ignota Labs leverages AI to revitalize failed drug candidates, increasing efficiency in the drug modification process and reducing costs significantly.
Investment tally shows big pharma pivot back to US already underwayUS pharma companies are returning manufacturing to America due to political pressures.
VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity NewsBig pharma competition for innovative Chinese-developed drugs is increasing, transforming the investment landscape.Foresite Capital is increasingly targeting assets from China, leveraging AI technology for drug development.
This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used to attract investors.Ignota Labs leverages AI to revitalize failed drug candidates, increasing efficiency in the drug modification process and reducing costs significantly.
Investment tally shows big pharma pivot back to US already underwayUS pharma companies are returning manufacturing to America due to political pressures.
VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity NewsBig pharma competition for innovative Chinese-developed drugs is increasing, transforming the investment landscape.Foresite Capital is increasingly targeting assets from China, leveraging AI technology for drug development.
AI Predicts Chemical Makeup From PhotosAI is transforming analytical chemistry by accurately predicting chemical compositions from images.
Google plans to release new 'open' AI models for drug discovery | TechCrunchGoogle is developing AI models for more efficient drug discovery called TxGemma.
Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunchLatent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.
AI Predicts Chemical Makeup From PhotosAI is transforming analytical chemistry by accurately predicting chemical compositions from images.
Google plans to release new 'open' AI models for drug discovery | TechCrunchGoogle is developing AI models for more efficient drug discovery called TxGemma.
Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunchLatent Labs is advancing AI to revolutionize protein design for biotech and pharmaceutical applications.
DeepMind CEO expects we'll pop AI-generated pills in 2025AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.
YC-backed ReactWise is applying AI to speed up drug manufacturing | TechCrunchReactWise uses AI to speed up drug manufacturing by optimizing chemical processes, significantly improving efficiency and accuracy.
French firm Bioptimus bags 74M - Silicon CanalsBioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.
Lindus Health raises $55M to 'fix the broken clinical trial industry' | TechCrunchLindus Health is transforming clinical trials through automation and machine learning to accelerate drug development.The company has raised $55 million to advance its mission in the growing CRO market.
DeepMind CEO expects we'll pop AI-generated pills in 2025AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.
YC-backed ReactWise is applying AI to speed up drug manufacturing | TechCrunchReactWise uses AI to speed up drug manufacturing by optimizing chemical processes, significantly improving efficiency and accuracy.
French firm Bioptimus bags 74M - Silicon CanalsBioptimus has secured $76M funding to enhance its AI platform for biological research, aiming to transform understanding and simulation of biology.
Lindus Health raises $55M to 'fix the broken clinical trial industry' | TechCrunchLindus Health is transforming clinical trials through automation and machine learning to accelerate drug development.The company has raised $55 million to advance its mission in the growing CRO market.
Hims & Hers (HIMS) Down 21% - Is the GLP-1 Gravy Train Over?Hims & Hers Health faces a significant stock drop due to the end of the Ozempic shortage, impacting its compounded drug market.
Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding DisputeThe ongoing demand for GLP-1s has resulted in a significant shortage and legal dispute regarding alternative compounding pharmacies.
The FDA has ordered a phaseout of knockoffs for these blockbuster weight-loss drugsThe FDA's decision will phase out off-brand copies of obesity and diabetes drugs, affecting access and pricing for consumers.
The FDA: Patients or Companies?The FDA must prioritize public health over the interests of pharmaceutical companies.
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.Tirzepatide is no longer in shortage, but this may limit access to cheaper compounded versions in 2025.
Hims & Hers (HIMS) Down 21% - Is the GLP-1 Gravy Train Over?Hims & Hers Health faces a significant stock drop due to the end of the Ozempic shortage, impacting its compounded drug market.
Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding DisputeThe ongoing demand for GLP-1s has resulted in a significant shortage and legal dispute regarding alternative compounding pharmacies.
The FDA has ordered a phaseout of knockoffs for these blockbuster weight-loss drugsThe FDA's decision will phase out off-brand copies of obesity and diabetes drugs, affecting access and pricing for consumers.
The FDA: Patients or Companies?The FDA must prioritize public health over the interests of pharmaceutical companies.
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.Tirzepatide is no longer in shortage, but this may limit access to cheaper compounded versions in 2025.
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts - TipRanks.comBeam Therapeutics shows promising results in gene editing, prompting analyst upgrades.Unity Software poised for growth with new ad platform Vector and improved fundamentals.Checkpoint Therapeutics downgraded due to acquisition uncertainties despite drug approval.Inuvo receives a 'Buy' rating for its innovative digital advertising solutions.
On Good Footing After a Polo TournamentDr. Mercaitis celebrated his new job at Pfizer by participating in a polo tournament.
Scimplify raises $40M to help manufacturers access specialty chemicals | TechCrunchScimplify raises $40 million to expand its specialty chemicals platform and target new markets, especially in the U.S.
Swiss-based InVirtuoLabs raises 2.85M to accelerate drug development with AI - Silicon CanalsInVirtuoLabs secures €2.85M funding to reduce drug development time and costs, enhancing accessibility to treatments.
Paris-based B2B platform for pharma sector Faks raises 6MFaks raises €6M to enhance its B2B platform, improving communication between pharmacies and pharmaceutical suppliers.
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, WegovyVerdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.
Eupry Secures 23M A-Round FundingEupry has secured €23 million in funding to enhance its temperature monitoring solutions and expand globally, particularly in the US market.
Scimplify raises $40M to help manufacturers access specialty chemicals | TechCrunchScimplify raises $40 million to expand its specialty chemicals platform and target new markets, especially in the U.S.
Swiss-based InVirtuoLabs raises 2.85M to accelerate drug development with AI - Silicon CanalsInVirtuoLabs secures €2.85M funding to reduce drug development time and costs, enhancing accessibility to treatments.
Paris-based B2B platform for pharma sector Faks raises 6MFaks raises €6M to enhance its B2B platform, improving communication between pharmacies and pharmaceutical suppliers.
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, WegovyVerdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.
Eupry Secures 23M A-Round FundingEupry has secured €23 million in funding to enhance its temperature monitoring solutions and expand globally, particularly in the US market.
The Nasdaq is Cratering But REGN, BIIB and CSGP Are Up Big TodayMarket uncertainty has intensified recession risks, impacting growth and spending.Regeneron Pharmaceuticals shows positive trial results despite market downturn.
Other Barks & Bites for Friday, March 7: Lashify Wins ITC Appeal on Economic Prong Analysis; CAFC Says Apple Did Not Violate Discovery Obligations at PTAB; and ParkerVision Files Reply Brief on Rule 36 Appeal at SCOTUSFederal Circuit clarified discovery obligations for IPR petitioners.Broadcom's AI chip demand positively impacted their Q1 results.Novo Nordisk is leading in anti-obesity drug patents.REPAIR Act aims to enhance automotive consumer rights.
An Enablement Defense is Disabled by the Federal CircuitThe Federal Circuit's ruling allows broad patent claims without enabling disclosure, disregarding standard patent law principles.
Other Barks & Bites for Friday, March 7: Lashify Wins ITC Appeal on Economic Prong Analysis; CAFC Says Apple Did Not Violate Discovery Obligations at PTAB; and ParkerVision Files Reply Brief on Rule 36 Appeal at SCOTUSFederal Circuit clarified discovery obligations for IPR petitioners.Broadcom's AI chip demand positively impacted their Q1 results.Novo Nordisk is leading in anti-obesity drug patents.REPAIR Act aims to enhance automotive consumer rights.
An Enablement Defense is Disabled by the Federal CircuitThe Federal Circuit's ruling allows broad patent claims without enabling disclosure, disregarding standard patent law principles.
Consumers can buy Zepbound direct from the drugmaker if they'll pay out of pocketEli Lilly's Zepbound reaches 100,000 direct buyers monthly, showing a shift towards online drug sales despite insurance coverage limitations.
One of Their Top Executives Was Gunned Down in Manhattan. Five Months Later, the Industry Partied Seven Blocks Away. It Was a Revealing Night.The 2025 PRWeek Healthcare Awards highlighted contrasting fortunes for major health companies amid industry turmoil.
This Growth Stock Surged 63% in 2024. Here's Why 2025 Could Bring An Even Bigger Gain.Eli Lilly stock has gained 63% in 2024, primarily due to the success of its Mounjaro weight-loss drug.
We know so little about taking weight-loss drugs without prescription is it really worth it? | Devi SridharThe popularity of GLP-1 drugs for weight loss is rising sharply, but concerns around safety and effectiveness remain largely unaddressed.
This Growth Stock Surged 63% in 2024. Here's Why 2025 Could Bring An Even Bigger Gain.Eli Lilly stock has gained 63% in 2024, primarily due to the success of its Mounjaro weight-loss drug.
We know so little about taking weight-loss drugs without prescription is it really worth it? | Devi SridharThe popularity of GLP-1 drugs for weight loss is rising sharply, but concerns around safety and effectiveness remain largely unaddressed.
Rare genetic disorder treated in womb for the first timeA child treated in the womb for spinal muscular atrophy shows no signs of the condition, marking a potential breakthrough in prenatal treatment.
Big Pharma and Big Ag: How They Control Your Health and FoodChronic disease rates in America surged from 7.5% in the 1930s to 60% today, connected to the agricultural industry's practices.
Offal exports: The lucrative trade fuelling pharma and smugglingCattle gallstones are highly valuable, now priced more than gold, indicating a lucrative opportunity for farmers.
Paper-based prescription bottle can help heal both patients and the planet - Yanko DesignThe first sustainable prescription pill bottle made from 100% recyclable paper is now available, offering an eco-friendly alternative to plastic bottles.
From the Beatles to biologics how Liverpool became a life science hotspotBristol Myers Squibb's expansion in Moreton illustrates the growing life sciences hub in Liverpool, further enhancing local research capacity and innovative drug development.
Paper-based prescription bottle can help heal both patients and the planet - Yanko DesignThe first sustainable prescription pill bottle made from 100% recyclable paper is now available, offering an eco-friendly alternative to plastic bottles.
From the Beatles to biologics how Liverpool became a life science hotspotBristol Myers Squibb's expansion in Moreton illustrates the growing life sciences hub in Liverpool, further enhancing local research capacity and innovative drug development.
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big TodayAbbVie's fourth-quarter earnings exceeded expectations, driven by strong sales of Skyrizi and Rinvoq.
Danish krone weakened by Novo Nordisk share price crashNovo Nordisk's disappointing drug trial results caused a significant drop in its share price, impacting Denmark's economy and currency.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Eli Lilly has demonstrated extraordinary stock growth and potential for future success through strategic moves and product endorsements.Looking ahead, the projected revenues and strategic industry positioning are vital for estimating Eli Lilly's stock trajectory.
Prediction: This Pharma Stock Will Be the Best Performer in 2025Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Eli Lilly's stock has increased significantly, reflecting strong performance and potential for future growth.The company's recent FDA approvals are critical drivers for its future stock price developments.
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?Merck beat earnings estimates but faces stock volatility due to weak full-year guidance.
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big TodayAbbVie's fourth-quarter earnings exceeded expectations, driven by strong sales of Skyrizi and Rinvoq.
Danish krone weakened by Novo Nordisk share price crashNovo Nordisk's disappointing drug trial results caused a significant drop in its share price, impacting Denmark's economy and currency.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Eli Lilly has demonstrated extraordinary stock growth and potential for future success through strategic moves and product endorsements.Looking ahead, the projected revenues and strategic industry positioning are vital for estimating Eli Lilly's stock trajectory.
Prediction: This Pharma Stock Will Be the Best Performer in 2025Market uncertainty deters investors from speculative industries; however, many biotech stocks are undervalued and present opportunities.Viking Therapeutics shows significant stock growth since its IPO and is anticipated to continue this upward trend.
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030Eli Lilly's stock has increased significantly, reflecting strong performance and potential for future growth.The company's recent FDA approvals are critical drivers for its future stock price developments.
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?Merck beat earnings estimates but faces stock volatility due to weak full-year guidance.
Hims and Hers Super Bowl Ad Sparks Controversy Over Weight Loss DrugsThe ad for Hims & Hers promotes weight-loss drugs while minimizing discussions of safety, leading to backlash from lawmakers and health professionals.
Hims & Hers faces backlash over 'misleading' Super Bowl ad-but it didn't stop stock from jumping over 11%Hims & Hers is defending its controversial Super Bowl ad against claims of misleading practices by the drug industry lobbying group.
Hims and Hers Super Bowl Ad Sparks Controversy Over Weight Loss DrugsThe ad for Hims & Hers promotes weight-loss drugs while minimizing discussions of safety, leading to backlash from lawmakers and health professionals.
Hims & Hers faces backlash over 'misleading' Super Bowl ad-but it didn't stop stock from jumping over 11%Hims & Hers is defending its controversial Super Bowl ad against claims of misleading practices by the drug industry lobbying group.
Novo Nordisk Annual Sales Jump on Demand for Ozempic and WegovyNovo Nordisk reported strong earnings in 2024 but expects slower sales growth in 2025 due to competition.The company’s share price has fallen dramatically amid uncertainties in the obesity drug market.
Ozempic, Wegovy may help mental health, substance disorders DW 01/27/2025Diabetes drugs Ozempic and Wegovy may reduce risk of mental health and addiction issues.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 - from an Ozempic-like pill to a triple-threat shotEli Lilly aims to develop a once-per-year weight-loss shot for easier obesity management.
Maire Treasa Ni Cheallaigh: Booming black market in Ozempic shows how harmful the stigma around obesity isWeight-loss drugs require careful medical supervision due to serious side effects and potential risks.
Ozempic, Wegovy may help mental health, substance disorders DW 01/27/2025Diabetes drugs Ozempic and Wegovy may reduce risk of mental health and addiction issues.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 - from an Ozempic-like pill to a triple-threat shotEli Lilly aims to develop a once-per-year weight-loss shot for easier obesity management.
Maire Treasa Ni Cheallaigh: Booming black market in Ozempic shows how harmful the stigma around obesity isWeight-loss drugs require careful medical supervision due to serious side effects and potential risks.
Larry Magid: Testing prescription, over-the-counter continuous glucose monitorsContinuous glucose monitoring is valuable for tracking blood sugar, even for non-diabetic individuals.
Daily briefing: Former NIH director Monica Bertagnolli talks TrumpScratching an itch activates the immune response, potentially protecting against infections and revealing a satisfying sensation for humans.
Larry Magid: Testing prescription, over-the-counter continuous glucose monitorsContinuous glucose monitoring is valuable for tracking blood sugar, even for non-diabetic individuals.
Daily briefing: Former NIH director Monica Bertagnolli talks TrumpScratching an itch activates the immune response, potentially protecting against infections and revealing a satisfying sensation for humans.
Common Side Effects' creators talked to a lot of people to get their conspiracy just rightAdult Swim's 'Common Side Effects' explores the absurdity of a reality where a perfect cure exists amid a conspiracy-driven narrative.
Why Johnson & Johnson's CEO Welcomes ScrutinyJohnson & Johnson is reshaping its portfolio by investing heavily in R&D and addressing legal challenges post-split from its consumer health division.
Medications, TMS, and Psychotherapy: A Holistic ApproachMulti-modal care shows 75 percent better outcomes than single treatments, advancing mental health approaches.
Supreme Court Preview: Will "Skinny Labels" Get a Weight Check?The Supreme Court will address the issue of generic drug manufacturers and potential patent infringement in the Hikma v. Amarin case.
Big data and Google BigQuery improve cancer drug development by detecting bacteria | Computer WeeklyUnderstanding the relationship between bacteria and drug efficacy is crucial for improving cancer treatment and drug trial success rates.
A Rift in Trump World Over How to Make America HealthierThe debate on tackling obesity pits lifestyle changes against pharmaceutical solutions, reflecting differing views on health strategies.
Quantum Computing: Revolution in Solving Complex ProblemsQuantum computing revolutionizes problem-solving by utilizing qubits for simultaneous calculations, vastly surpassing traditional computational methods.
Structures and mechanism of condensation in nonribosomal peptide synthesisNRPSs efficiently synthesize important pharmaceuticals through mechanism characterized by concerted reaction involving key catalytic sites.